Premium
Non‐antiplatelet effect of clopidogrel: improving endothelial function in C hinese healthy subjects with different CYP 2C19 genotype
Author(s) -
Zhang YinZhuang,
Chen BiLian,
Zhang Wei,
Cao Xin
Publication year - 2015
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.12325
Subject(s) - clopidogrel , adenosine diphosphate , platelet , pharmacology , medicine , adenosine , p2y12 , platelet aggregation , myocardial infarction
Summary Clopidogrel has been shown to improve endothelial function in vitro and in patients with coronary artery disease. However, it remains unclear whether such an effect of clopidogrel is associated with CYP 2C19 polymorphisms that determine the antiplatelet effect of clopidogrel. After genotyping, 12 healthy participants were enrolled in the study. Among them, six participants were CYP 2C19 *1/*1 (extensive metabolizers; EM ) and the other six participants were CYP 2C19 * 2/*2 or *3 (poor metabolizers; PM ). All participants received 300 mg clopidogel orally. Endothelial function was assessed by measurement of flow‐mediated dilation of the brachial artery, and adenosine diphosphate‐induced platelet aggregation was determined by using optical aggregometry at 0, 4 and 24 h after administration of 300 mg clopidogrel. Flow‐mediated dilation was significantly higher at 4 and 24 h after a loading‐dose administration of clopidogrel in both the CYP 2C19 EM and PM groups, but showed no significant difference between the two groups. Adenosine diphosphate‐induced platelet aggregation was significantly inhibited at 4 and 24 h after administration of clopidogrel in the CYP 2C19 EM group. However, there was no statistical correlation between the change in flow‐mediated dilation and adenosine diphosphate‐induced platelet aggregation in the two CYP 2C19 groups. This is the first study to report that clopidogrel improves endothelial function in healthy Chinese subjects, which is unrelated with the CYP 2C19 genotype and independent of antiplatelet action.